Sensei Biotherapeutics (SNSE) P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.26
Average-0.2805
Median-0.2800
Minimum-0.3100
Maximum-0.2600
-0.26
Past Month+0.04 (13.33%)
The P/E ratio for Sensei Biotherapeutics (SNSE) is -0.26 as of Jun 13, 2025. This represents a decrease of -36.59% compared to its 12-month average P/E ratio of -0.41. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Sensei Biotherapeutics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Sensei Biotherapeutics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Sensei Biotherapeutics to industry peers.
Sensei Biotherapeutics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Sensei Biotherapeutics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Sensei Biotherapeutics to industry peers.
Sensei Biotherapeutics (SNSE) P/E Ratio Insights
See Sensei Biotherapeutics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Sensei Biotherapeutics (SNSE)
Order type
Buy in
Order amount
Est. shares
0 shares
Sensei Biotherapeutics (SNSE) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $0.3152 | -0.27 |
| May 1, 2025 | $0.3996 | -0.33 |
| Apr 1, 2025 | $0.345 | -0.29 |
| Mar 3, 2025 | $0.431 | -0.36 |
| Feb 3, 2025 | $0.4777 | -0.40 |
| Jan 2, 2025 | $0.515 | -0.43 |
Sensei Biotherapeutics (SNSE) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.26 | -36.59% |
| 2024 | -0.41 | -22.64% |
| 2023 | -0.53 | -47.00% |
| 2022 | -1.00 | -79.25% |
| 2021 | -4.82 | — |
FAQs About Sensei Biotherapeutics (SNSE) P/E ratio
The latest P/E ratio of Sensei Biotherapeutics (SNSE) is -0.26, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Sensei Biotherapeutics’s last 12-month average P/E ratio is -0.41, compared to its current P/E ratio of -0.26. This reflects a decrease of -36.59%.
Sensei Biotherapeutics’s current P/E ratio of -0.26 is lower than its last 12-month average P/E of -0.41. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Sensei Biotherapeutics’s average P/E ratio over the last 3 years is -0.75. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Sensei Biotherapeutics’s average P/E ratio over the last 5 years is -3.42. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.